Phase II Study of Regorafenib Continuous Dosing of Regorafenib in Patients With GISTs
Clinical trial NCT02889328 · COMPLETED
Trial details
- NCT number
- NCT02889328
- Sponsor
- Asan Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2017-08-09
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.